目次

Table of Contents

1. Oncology Drugs Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction
6.1. Segmentation By Geography
6.2. Segmentation By Type
6.3. Segmentation By Drug Class Type
6.4. Segmentation By Distribution Channel
6.5. Segmentation By Route Of Administration
6.6. Segmentation By Drug Classification

7. Oncology Drugs Market Characteristics
7.1. Market Definition
7.2. Market Segmentation By Type
7.2.1. Lung Cancer Drugs
7.2.2. Pancreatic Cancer Drugs
7.2.3. Breast Cancer Drugs
7.2.4. Prostate Cancer Drugs
7.2.5. Ovarian Cancer Drugs
7.2.6. Colorectal Cancer Drugs
7.2.7. Gastric Cancer Drugs
7.2.8. Kidney Cancer Drugs
7.2.9. Brain Tumor Drugs
7.2.10. Thyroid Cancer Drugs
7.2.11. Skin Cancer Drugs
7.2.12. Bladder Cancer Drugs
7.2.13. Cervical Cancer Drugs
7.2.14. Blood Cancer Drugs
7.2.15. Others
7.3. Market Segmentation By Drug Class Type
7.3.1. Chemotherapy
7.3.2. Targeted Therapy
7.3.3. Immunotherapy (Biologic Therapy)
7.3.4. Hormonal Therapy
7.4. Market Segmentation By Distribution Channel
7.4.1. Hospital Pharmacies
7.4.2. Retail Pharmacies/Drug Stores
7.4.3. Other Pharmacies
7.5. Market Segmentation By Route Of Administration
7.5.1. Oral
7.5.2. Parenteral
7.5.3. Others
7.6. Market Segmentation By Drug Classification
7.6.1. Branded Drugs
7.6.2. Generic Drugs

8. Oncology Drugs Market, Supply Chain Analysis
8.1. Raw Material Suppliers
8.2. Contract Research Organization (CRO)
8.3. Oncology Drugs Manufacturer
8.3.1. Drug Discovery
8.3.2. Preclinical And Clinical Trials
8.3.3. Patents Upon Discovery And Approval
8.3.4. Drug Manufacturing
8.4. Contract Manufacturing Organization (CMO)
8.5. Wholesalers/Distributors
8.6. Retailers (Pharmacies) And Hospitals
8.7. Oncologists
8.8. End-Users

9. Oncology Drugs Market, Product/Service Analysis -Product/Service Examples

10. Oncology Drugs Market Customer Information
10.1. Cancer Patients Need More Knowledge On Their Treatment
10.2. COVID-19 Pandemic Effects On Cancer Patients and Survivors
10.3. Pharma Salespeople Are A Major Influence On Oncologists
10.4. Only 17% Of Cancer Patients Are Treated Right
10.5. Major Challenges To Future Cancer Program Growth
10.6. Americans Taking More Prescription Drugs than Ever
10.7. Increasing Intake of Prescription Drugs
10.8. Dutch Patients Highly Satisfied With Information On Chemotherapy
10.9. High Cost Of Treatment

11. Oncology Drugs Market Trends And Strategies
11.1. Development And Increasing Demand For Next Generation Biologics
11.2. Innovation in Patient Therapies (New Active Substances)
11.3. CRISPR-Cas9 Technology Use In Cancer Treatment
11.4. Expansion Of Cell And Gene Therapy & CAR-T Approvals
11.5. Development Of Personalized Cancer Vaccines
11.6. Microneedle Pills
11.7. Rising Focus On Immunotherapy Drugs For Cancer Treatment
11.8. Development Of New Drugs To Treat Blood Cancer
11.9. Collaboration Driving Innovation
11.10. Investment In Artificial Intelligence For Oncology Drugs
11.11. Use Of 3D Printing To Test New Oncology Drugs
11.12. Rising Focus On Targeted Therapy
11.13. Shift Towards Oral Chemotherapy Drugs

12. Leading Oncology Drug Therapies
12.1. Chemotherapy
12.2. Targeted Therapy
12.3. Immunotherapy (Biologic Therapy)
12.4. Hormonal Therapy
12.5. Radiation Therapy

13. Gene Therapy In Oncology
13.1. Artificial Cell Stimulation
13.2. Oncolytic Virotherapy
13.3. Gene Transfer
13.4. Others

14. Unmet Needs In Oncology Drugs
14.1. Novel Mechanism Of Action
14.2. Less Treatment Options Available For Rare Cancers
14.3. Unfavorable Benefits/Risk
14.4. Intractable Tumors
14.5. Intractable Tumors Subsets
14.6. Rare Or Unclassifiable Tumors

15. Oncology Drugs In Pipeline

16. Top 10 Drugs In The Global Oncology drugs Market

17. COVID Impact On The Oncology Drugs Market
17.1. Clinical Trial Delays
17.2. Low Usage Of Drugs
17.3. Supply Chain Issues

18. Global Oncology Drugs Market Size And Growth
18.1. Market Size
18.2. Historic Market Growth, 2015 - 2020, Value ($ Million)
18.2.1. Drivers Of The Market 2015 - 2020
18.2.2. Restraints On The Market 2015 - 2020
18.3. Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
18.3.1. Drivers Of The Market 2020 - 2025
18.3.2. Restraints On The Market 2020 - 2025

19. Oncology Drugs Market, Regional Analysis
19.1. Global Oncology Drugs Market, By Region, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
19.2. Global Oncology Drugs Market, 2015 - 2025, Historic And Forecast, By Region
19.3. Global Oncology Drugs Market, 2020 - 2025, Growth And Market Share Comparison, By Region

20. Global Oncology Drugs Market Segmentation
20.1. Global Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
20.1.1. Blood Cancer drugs
20.1.2. Breast Cancer drugs
20.1.3. Lung Cancer drugs
20.1.4. Prostate Cancer drugs
20.1.5. Colorectal Cancer drugs
20.1.6. Cervical Cancer drugs
20.1.7. Kidney Cancer drugs
20.1.8. Gastric Cancer drugs
20.1.9. Brain Tumor drugs
20.1.10. Ovarian Cancer drugs
20.1.11. Skin Cancer drugs
20.1.12. Bladder Cancer drugs
20.1.13. Pancreatic Cancer
20.1.14. Thyroid Cancer drugs
20.2. Global Oncology Drugs Market, Segmentation By Drug Class Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Billion)
20.3. Global Oncology Drugs Market, Segmentation By Distribution Channel, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
20.3.1. Hospital Pharmacies
20.3.2. Retail Pharmacies/Drug Stores
20.3.3. Other Distribution Channels
20.4. Global Oncology Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
20.4.1. Parenteral
20.4.2. Oral
20.4.3. Others
20.5. Global Oncology Drugs Market, Segmentation By Drug Classification, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

21. Global Oncology Drugs Market Comparison with Macro Economic Factors
21.1. Oncology Drugs Market Size, Percentage Of GDP, Global
21.2. Per Capita Average Oncology Drugs Market Expenditure, Global

22. Asia-Pacific Oncology Drugs Market
22.1. Asia-Pacific Oncology Drugs Market Overview
22.1.1. Region Information
22.1.2. COVID-19 Impact
22.1.3. Market Information
22.1.4. Background Information
22.1.5. New Drug Approvals
22.1.6. Government Initiatives
22.1.7. Regulations
22.1.8. Regulatory Bodies
22.1.9. Major Associations
22.1.10. Taxes Levied
22.1.11. Corporate Tax Structure
22.1.12. Investment
22.1.13. Major Companies
22.2. Asia-Pacific Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
22.3. Asia-Pacific Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
22.4. Asia-Pacific Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
22.5. Asia-Pacific Oncology Drugs Market, 2020, By Country, Value ($ Million)
22.6. Asia-Pacific Oncology Drugs Market, 2015 - 2025, Historic And Forecast, By Country
22.7. Asia-Pacific Oncology Drugs Market, 2020 - 2025, Growth And Market Share Comparison, By Country
22.8. Asia-Pacific Oncology Drugs Market Metrics
22.8.1. Per Capita Oncology Drugs Expenditure, 2020, Asia-Pacific Major Countries
22.9. Asia-Pacific Oncology Drugs Market: Country Analysis
22.10. China Oncology Drugs Market
22.11. China Oncology Drugs Market Overview
22.11.1. Country Information
22.11.2. COVID-19 Impact
22.11.3. Market Information
22.11.4. Background Information
22.11.5. New Drug Approvals
22.11.6. Government Initiatives
22.11.7. Regulations
22.11.8. Regulatory Bodies
22.11.9. Major Associations
22.11.10. Taxes Levied
22.11.11. Corporate Tax Structure
22.11.12. Investment
22.11.13. Major Companies
22.12. China Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
22.13. China Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
22.14. China Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
22.15. Australia Oncology Drugs Market
22.16. Australia Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
22.17. Australia Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
22.18. Australia Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
22.19. Hong Kong Oncology Drugs Market
22.20. Hong Kong Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
22.21. Hong Kong Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
22.22. India Oncology Drugs Market
22.23. India Oncology Drugs Market Overview
22.23.1. Country Information
22.23.2. COVID-19 Impact
22.23.3. Market Information
22.23.4. Background Information
22.23.5. New Drug Approvals
22.23.6. Government Initiatives
22.23.7. Regulations
22.23.8. Regulatory Bodies
22.23.9. Major Associations
22.23.10. Taxes Levied
22.23.11. Corporate Tax Structure
22.23.12. Investments
22.23.13. Major Companies
22.24. India Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
22.25. India Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
22.26. India Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
22.27. Indonesia Oncology Drugs Market
22.28. Indonesia Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
22.29. Indonesia Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
22.30. Indonesia Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
22.31. Japan Oncology Drugs Market
22.32. Japan Oncology Drugs Market Overview
22.32.1. Region Information
22.32.2. COVID-19 Impact
22.32.3. Market Information
22.32.4. Background Information
22.32.5. New Drug Approvals
22.32.6. Government Initiatives
22.32.7. Regulations
22.32.8. Regulatory Bodies
22.32.9. Major Associations
22.32.10. Taxes Levied
22.32.11. Corporate Tax Structure
22.32.12. Investments
22.32.13. Major Companies
22.33. Japan Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
22.34. Japan Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
22.35. Japan Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
22.36. Malaysia Oncology Drugs Market
22.37. Malaysia Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
22.38. Malaysia Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
22.39. New Zealand Oncology Drugs Market
22.40. New Zealand Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
22.41. New Zealand Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
22.42. Philippines Oncology Drugs Market
22.43. Philippines Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
22.44. Philippines Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
22.45. Singapore Oncology Drugs Market
22.46. Singapore Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
22.47. Singapore Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
22.48. South Korea Oncology Drugs Market
22.49. South Korea Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
22.50. South Korea Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
22.51. South Korea Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
22.52. Thailand Oncology Drugs Market
22.53. Thailand Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
22.54. Thailand Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
22.55. Vietnam Oncology Drugs Market
22.56. Vietnam Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
22.57. Vietnam Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)

23. Western Europe Oncology Drugs Market
23.1. Western Europe Oncology Drugs Market Overview
23.1.1. Region Information
23.1.2. COVID-19 Impact
23.1.3. Market Information
23.1.4. Background Information
23.1.5. New Drug Approvals
23.1.6. Government Initiatives
23.1.7. Regulations
23.1.8. Regulatory Bodies
23.1.9. Major Associations
23.1.10. Taxes Levied
23.1.11. Corporate Tax Structure
23.1.12. Investment
23.1.13. Major Companies
23.2. Western Europe Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
23.3. Western Europe Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
23.4. Western Europe Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
23.5. Western Europe Oncology Drugs Market, 2020, By Country, Value ($ Million)
23.6. Western Europe Oncology Drugs Market, 2015 - 2025, Historic And Forecast, By Country
23.7.Western Europe Oncology Drugs Market, 2020 - 2025, Growth And Market Share Comparison, By Country
23.8. Western Europe Oncology Drugs Market Metrics
23.8.1. Per Capita Oncology Drugs Expenditure, 2020, Western Europe Major Countries
23.9. Western Europe Oncology Drugs Market: Country Analysis
23.10. Austria Oncology Drugs Market
23.11. Austria Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
23.12. Austria Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
23.13. Belgium Oncology Drugs Market
23.14. Belgium Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
23.15. Belgium Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
23.16. Denmark Oncology Drugs Market
23.17. Denmark Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
23.18. Denmark Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
23.19. Finland Oncology Drugs Market
23.20. Finland Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
23.21. Finland Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
23.22. France Oncology Drugs Market
23.23. France Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
23.24. France Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
23.25. France Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
23.26. Germany Oncology Drugs Market
23.27. Germany Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
23.28. Germany Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
23.29. Germany Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
23.30. Ireland Oncology Drugs Market
23.31. Ireland Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
23.32. Ireland Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
23.33. Italy Oncology Drugs Market
23.34. Italy Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
23.35. Italy Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
23.36. Netherlands Oncology Drugs Market
23.37. Netherlands Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
23.38. Netherlands Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
23.39. Norway Oncology Drugs Market
23.40. Norway Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
23.41. Norway Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
23.42. Portugal Oncology Drugs Market
23.43. Portugal Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
23.44. Portugal Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
23.45. Spain Oncology Drugs Market
23.46. Spain Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
23.47. Spain Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
23.48. Sweden Oncology Drugs Market
23.49. Sweden Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
23.50. Sweden Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
23.51. Switzerland Oncology Drugs Market
23.52. Switzerland Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
23.53. Switzerland Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
23.54. UK Oncology Drugs Market
23.55. UK Oncology Drugs Market Overview
23.55.1. Country Information
23.55.2. COVID-19 Impact
23.55.3. Market Information
23.55.4. Background Information
23.55.5. New Drug Approvals
23.55.6. Government Initiatives
23.55.7. Regulations
23.55.8. Regulatory Bodies
23.55.9. Major Associations
23.55.10. Taxes Levied
23.55.11. Corporate Tax Structure
23.55.12. Investments
23.55.13. Major Companies
23.56. UK Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
23.57. UK Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
23.58. UK Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

24. Eastern Europe Oncology Drugs Market
24.1. Eastern Europe Oncology Drugs Market Overview
24.1.1. Region Information
24.1.2. COVID-19 Impact
24.1.3. Market Information
24.1.4. Background Information
24.1.5. New Drug Approvals
24.1.6. Government Initiatives
24.1.7. Regulations
24.1.8. Regulatory Bodies
24.1.9. Major Associations
24.1.10. Taxes Levied
24.1.11. Corporate Tax Structure
24.1.12. Investments
24.1.13. Major Companies
24.2. Eastern Europe Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
24.3. Eastern Europe Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
24.4. Eastern Europe Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
24.5. Eastern Europe Oncology Drugs Market, 2020, By Country, Value ($ Million)
24.6. Eastern Europe Oncology Drugs Market, 2015 - 2025, Historic And Forecast, By Country
24.7. Eastern Europe Oncology Drugs Market, 2020 - 2025, Growth And Market Share Comparison, By Country
24.8. Eastern Europe Oncology Drugs Market Metrics
24.8.1. Per Capita Oncology Drugs Expenditure, 2020, Eastern Europe Major Countries
24.9. Eastern Europe Oncology Drugs Market: Country Analysis
24.10. Czech Republic Oncology Drugs Market
24.11. Czech Republic Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
24.12. Czech Republic Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
24.13. Poland Oncology Drugs Market
24.14. Poland Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
24.15. Poland Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
24.16. Romania Oncology Drugs Market
24.17. Romania Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
24.18. Romania Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
24.19. Russia Oncology Drugs Market
24.20. Russia Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
24.21. Russia Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
24.22. Russia Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

25. North America Oncology Drugs Market
25.1. North America Oncology Drugs Market Overview
25.1.1. Region Information
25.1.2. COVID-19 Impact
25.1.3. Market Information
25.1.4. Background Information
25.1.5. New Drug Approvals
25.1.6. Government Initiatives
25.1.7. Regulations
25.1.8. Regulatory Bodies
25.1.9. Major Associations
25.1.10. Taxes Levied
25.1.11. Corporate Tax Structure
25.1.12. Investments
25.1.13. Major Companies
25.2. North America Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
25.3. North America Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
25.4. North America Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
25.5. North America Oncology Drugs Market, 2020, By Country, Value ($ Million)
25.6. North America Oncology Drugs Market, 2015 - 2025, Historic And Forecast, By Country
25.7.North America Oncology Drugs Market, 2020 - 2025, Growth And Market Share Comparison, By Country
25.8. North America Oncology Drugs Market Metrics
25.8.1. Per Capita Oncology Drugs Expenditure, 2020, North America Major Countries
25.9. North America Oncology Drugs Market: Country Analysis
25.10. Canada Oncology Drugs Market
25.11. Canada Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
25.12. Canada Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
25.13. Mexico Oncology Drugs Market
25.14. Mexico Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
25.15. Mexico Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
25.16. USA Oncology Drugs Market
25.17. USA Oncology Drugs Market Overview
25.17.1. Country Information
25.17.2. COVID-19 Impact
25.17.3. Market Information
25.17.4. Background Information
25.17.5. New Drug Approvals
25.17.6. Government Initiatives
25.17.7. Regulations
25.17.8. Regulatory Bodies
25.17.9. Major Associations
25.17.10. Taxes Levied
25.17.11. Corporate Tax Structure
25.17.12. Investments
25.17.13. Major Companies
25.18. USA Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
25.19. USA Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
25.20. USA Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

26. South America Oncology Drugs Market
26.1. South America Oncology Drugs Market Overview
26.1.1. Region Information
26.1.2. COVID-19 Impact
26.1.3. Market Information
26.1.4. Background Information
26.1.5. New Drug Approvals
26.1.6. Government Initiatives
26.1.7. Regulations
26.1.8. Regulatory Bodies
26.1.9. Major Associations
26.1.10. Taxes Levied
26.1.11. Corporate Tax Structure
26.1.12. Investments
26.1.13. Major Companies
26.2. South America Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
26.3. South America Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
26.4. South America Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
26.5. South America Oncology Drugs Market, 2020, By Country, Value ($ Million)
26.6. South America Oncology Drugs Market, 2015 - 2025, Historic And Forecast, By Country
26.7. South America Oncology Drugs Market, 2020 - 2025, Growth And Market Share Comparison, By Country
26.8. South America Oncology Drugs Market Metrics
26.8.1. Per Capita Oncology Drugs Expenditure, 2020, South America Major Countries
26.9. South America Oncology Drugs Market: Country Analysis
26.10. Argentina Oncology Drugs Market
26.11. Argentina Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
26.12. Argentina Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
26.13. Brazil Oncology Drugs Market
26.14. Brazil Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
26.15. Brazil Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
26.16. Brazil Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
26.17. Chile Oncology Drugs Market
26.18. Chile Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
26.19. Chile Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
26.20. Colombia Oncology Drugs Market
26.21. Colombia Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
26.22. Colombia Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
26.23. Peru Oncology Drugs Market
26.24. Peru Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
26.25. Peru Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
26.26. Venezuela Oncology Drugs Market
26.27. Venezuela Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
26.28. Venezuela Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)

27. Middle East Oncology Drugs Market
27.1. Middle East Oncology Drugs Market Overview
27.1.1. Region Information
27.1.2. COVID-19 Impact
27.1.3. Market Information
27.1.4. Background Information
27.1.5. New Drug Approvals
27.1.6. Government Initiatives
27.1.7. Regulations
27.1.8. Regulatory Bodies
27.1.9. Associations
27.1.10. Taxes Levied
27.1.11. Corporate Tax Structure
27.1.12. Investments
27.1.13. Major Companies
27.2. Middle East Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
27.3.Middle East Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
27.4. Middle East Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
27.5.Middle East Oncology Drugs Market, 2020, By Country, Value ($ Million)
27.6. Middle East Oncology Drugs Market, 2015 - 2025, Historic And Forecast, By Country
27.7. Middle East Oncology Drugs Market, 2020 - 2025, Growth And Market Share Comparison, By Country
27.8. Middle East Oncology Drugs Market Metrics
27.8.1. Per Capita Oncology Drugs Expenditure, 2020, Middle East Major Countries
27.9. Middle East Oncology Drugs Market: Country Analysis
27.10. Saudi Arabia Oncology Drugs Market
27.11. Saudi Arabia Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
27.12. Saudi Arabia Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
27.13. Israel Oncology Drugs Market
27.14. Israel Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
27.15. Israel Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
27.16. Turkey Oncology Drugs Market
27.17. Turkey Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
27.18. Turkey Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
27.19. UAE Oncology Drugs Market
27.20. UAE Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
27.21. UAE Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)

28. Africa Oncology Drugs Market
28.1. Africa Oncology Drugs Market Overview
28.1.1. Region Information
28.1.2. COVID-19 Impact
28.1.3. Market Information
28.1.4. Background Information
28.1.5. Government Initiatives
28.1.6. Regulations
28.1.7. Regulatory Bodies
28.1.8. Major Associations
28.1.9. Taxes Levied
28.1.10. Corporate Tax Structure
28.1.11. Investments
28.1.12. Major Companies
28.2. Africa Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
28.3. Africa Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
28.4. Africa Oncology Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
28.5. Africa Oncology Drugs Market, 2020, By Country, Value ($ Million)
28.6. Africa Oncology Drugs Market, 2015 - 2025, Historic And Forecast, By Country
28.7. Africa Oncology Drugs Market, 2020 - 2025, Growth And Market Share Comparison, By Country
28.8. Africa Oncology Drugs Market Metrics
28.8.1. Per Capita Oncology Drugs Expenditure, 2020, Middle East Major Countries
28.9. Africa Oncology Drugs Market: Country Analysis
28.10. Egypt Oncology Drugs Market
28.11. Egypt Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
28.12. Egypt Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
28.13. Nigeria Oncology Drugs Market
28.14. Nigeria Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
28.15. Nigeria Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)
28.16. South Africa Oncology Drugs Market
28.17. South Africa Oncology Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
28.18. South Africa Oncology Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F, Value ($ Million)

29. Global Oncology Drugs Market Competitive Landscape
29.1. Company Profiles
29.2. Bristol-Myers Squibb Company
29.2.1. Company Overview
29.2.2. Products And Services
29.2.3. Business Strategy
29.2.4. Financial overview
29.3. F. Hoffmann-La Roche AG
29.3.1. Company Overview
29.3.2. Products And Services
29.3.3. Business Strategy
29.3.4. Financial Overview
29.4. Merck & Co., Inc.
29.4.1. Company Overview
29.4.2. Products And Services
29.4.3. Business Strategy
29.4.4. Financial Overview
29.5. Novartis AG
29.5.1. Company Overview
29.5.2. Products And Services
29.5.3. Business Strategy
29.5.4. Financial Overview
29.6. Johnson & Johnson
29.6.1. Company Overview
29.6.2. Products And Services
29.6.3. Business Strategy
29.6.4. Financial Overview

30. Key Mergers And Acquisitions In The Oncology Drugs Market
30.1. Servier Laboratories Acquired Agios Pharmaceuticals
30.2. Boehringer Ingelheim Acquired NBE-Therapeutics
30.3. Merck & Co. to Acquired VelosBio Inc
30.4. Gilead Sciences, Inc. Acquired Immunomedics, Inc.
30.5. Gilead Sciences, Inc. Acquired Forty Seven, Inc.
30.6. Gilead Sciences, Inc. Acquired 49.9% Equity In Pionyr Immunotherapeutics Inc.
30.7.Mediolanum Farmaceutici Acquired ElsaLys Biotech
30.8. True North Acquired Minority Stake In Biocon Biologics Ltd.
30.9. PAG Acquired Stake In Hisun BioRay
30.10. Eli Lilly And Company Acquired Loxo Oncology, Inc.
30.11. Fuji Pharma Co., Ltd. Acquired Stake In Alvotech
30.12. Bristol-Myers Squibb Acquired Celgene Corporation
30.13. Kashiv Pharma, LLC Acquired Adello Biologics
30.14. Takeda Pharmaceutical Company Limited Acquired Shire Plc
30.15. GlaxoSmithKline Plc Acquired Tesaro, Inc.
30.16. Mundipharma International Limited Acquired Cinfa Biotech
30.17. F. Hoffmann-La Roche AG Acquired Tusk Therapeutics Ltd
30.18. Eli Lilly And Company Acquired ARMO BioSciences, Inc.
30.19. Threshold Pharmaceuticals Merged With Molecular Templates, Inc.
30.20. Ipsen Acquired Oncology Assets From Merrimack Pharmaceuticals
30.21. Takeda Pharmaceutical Company Limited Acquired ARIAD Pharmaceuticals, Inc.
30.22. Sumitomo Dainippon Pharma Co., Ltd. Acquired Tolero Pharmaceuticals, Inc.
30.23. Astellas Pharma Inc. Acquired GANYMED Pharmaceuticals AG

31. Market Background: Pharmaceutical Drugs Market
31.1.Pharmaceutical Drugs Market Characteristics
31.1.1. Market Definition
31.1.2. Segmentation By Type
31.2. Global Pharmaceutical Drugs Market, Segmentation By Type, 2015 - 2025, Value ($ Billion)
31.3.Global Pharmaceutical Drugs Market, 2020, By Region, Value ($ Billion)
31.4. Global Pharmaceutical Drugs Market, 2015 - 2025, Historic And Forecast, By Region

32. Oncology Drugs Market, Opportunities And Strategies
32.1. Global Oncology Drugs Market In 2025 - Countries Offering Most New Opportunities
32.2. Global Oncology Drugs Market In 2025 - Segments Offering Most New Opportunities
32.3. Global Oncology Drugs Market In 2025 - Growth Strategies
32.3.1. Market Trend Based Strategies
32.3.2. Competitor Strategies

33. Oncology Drugs Market, Conclusions And Recommendations
33.1. Conclusions
33.2. Recommendations
33.2.1. Product
33.2.2. Price
33.2.3. Place
33.2.4. Promotion

34. Appendix
34.1. Market Data Sources
34.2. NAICS Definitions Of Industry Covered In This Report
34.3. Research Methodology
34.4. Currencies
34.5. Research Inquiries
34.6. The Business Research Company
34.7. Copyright and Disclaimer